Placental growth factor (PlGF) is an increasingly important molecule in the prediction,
diagnosis and treatment of pre-eclampsia. It has pro-angiogenic effects on the feto-placental …

Preeclampsia continues to afflict 5% to 8% of all pregnancies throughout the world and is
associated with significant morbidity and mortality to the mother and the fetus. Although the …

Normal pregnancy is associated with marked hemodynamic and uterine changes that allow
adequate uteroplacental blood flow and uterine expansion for the growing fetus. These …

This review is divided into three parts. The first part briefly describes the pathogenesis of
preeclampsia. This is followed by reviewing previously reported management strategies of …

Preeclampsia is a life-threatening vascular disorder of pregnancy due to a failing stressed
placenta. Millions of women risk death to give birth each year and globally each year, almost …

The incidence of acute kidney injury in pregnancy (P-AKI) has declined significantly over the
last three decades in developing countries. However, it is still associated with significant …

Pre-eclampsia is a common obstetric complication globally responsible for a significant
burden of maternal and perinatal morbidity and mortality. Central to its pathophysiology is …

Stroke remains a leading cause of mortality and disability worldwide. More women than men
have strokes each year, in part because women live longer. Women have poorer functional …

Preeclampsia is a hypertensive disorder of pregnancy, classically defined as new-onset
hypertension and proteinuria of at least 300 mg in 24 h. It is among the most common …

Patients with preeclampsia display elevated placenta-derived sFlt-1 (soluble Fms-like
tyrosine kinase-1) and endoglin levels and decreased placental growth factor levels. Proton …